Profile
MNMD NVO VRTX REGN SGEN ARGX
Company Name Mind Medicine (MindMed) Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $477.39M $362.58B $107.38B $74.92B $43.15B $39.83B
Employees 0.06K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Mr. Robert Barrow Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
MNMD NVO VRTX REGN SGEN ARGX
Quant Rating Score 2 3 4 4 3 1
Quant Rating Sell Neutral Buy Buy Neutral Strong Sell
Trading
MNMD NVO VRTX REGN SGEN ARGX
Last Close $6.51 $83.07 $416.96 $693.23 $228.74 $659.81
High 52 $11.75 $146.91 $516.74 $1201.76 $228.74 $670.4
Low 52 $3.55 $81.18 $392.81 $690.87 $228.74 $356.01
Price vs. 52 Week High -44.6 % -43.46 % -19.31 % -42.32 % 0 % -1.58 %
Price vs. 52 Week Low 83.38 % 2.33 % 6.15 % 0.34 % 0 % 85.33 %
Total Return
MNMD NVO VRTX REGN SGEN ARGX
1 Month Return -12.97 % -23.09 % -11.14 % -6.32 % 0 % 3.37 %
3 Month Return 1.48 % -29.73 % -16.4 % -30.53 % 0 % 21.44 %
6 Month Return -22.41 % -38.66 % -14.62 % -36.14 % 0 % 42.38 %
9 Month Return -31.69 % -33.29 % 6.07 % -23.08 % 0 % 80.18 %
YTD Return -6.47 % -3.43 % 3.54 % -2.68 % 0 % 7.29 %
1 Year Return 71.77 % -22.15 % -3.87 % -25.39 % 0 % 77.1 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MNMD NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.67 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
MNMD NVO VRTX REGN SGEN ARGX
Asset Growth -26.74 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth 1.89 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth - 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year - 90.03 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year - 123.63 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year - 65.69 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth -41.51 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth -102.56 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share -27.24 % 106.26 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share 16.87 % 133.27 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share -108.45 % 98.1 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth -41.51 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) -28.37 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG -23.63 % 117.73 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG -199.66 % 162.84 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG -178.91 % 150.28 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth -59.48 % 51.88 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth -59.48 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -59.2 % 28.67 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share -53.32 % 74.77 % 104.06 % 137.56 % 33.72 % 93.75 %
Share Holder 5 Year Equity Growth Per Share -72.35 % 121.34 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share -44.53 % 49.24 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth - 26.56 % - - - -
Dividend 3 Year Growth Per Share - 63.98 % - - - -
Dividend 5 Year Growth Per Share - 79.57 % - - - -
Dividend 10 Year Growth Per Share - 94.94 % - - - -
Debt Growth 19523.61 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth -28.37 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
MNMD NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 72.78 % 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM -30.59 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -52.98 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -32.69 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 104.42 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -1935.9 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM -301.57 % 207.5 % -49.48 % 157.08 % -185.98 % -428.57 %
Receivables Turnover TTM - 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 0.61 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM - 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 1.51 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -0.94 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -0.94 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 379.01 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -1515.41 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM -301.57 % 207.5 % -49.48 % 157.08 % -185.98 % -428.57 %
Price To Free Cash Flows Ratio TTM -6.51 38.52 -92.27 22.18 -141.85 -188.58
Price To Operating Cash Flows Ratio TTM -6.92 22.3 -127.67 17.64 -203.89 -272.4
Price Cash Flow Ratio TTM -6.92 22.3 -127.67 17.64 -203.89 -272.4
Income Statement (TTM)
MNMD NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $-0B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 0% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.09B $113.33B $4.61B $4.69B $-0.62B $-0.22B
Net Income $-0.1B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -2.44 9.31 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
MNMD NVO VRTX REGN SGEN ARGX
Long Term Debt $0.01B $20.53B $0.72B $2.7B $0.04B $0.02B
Total Liabilities $0.05B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.08B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0.01B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.12B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
MNMD NVO VRTX REGN SGEN ARGX
Net Income $-0.1B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.98
ABCL AbCellera Biologics Inc. 2.97
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.21
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.65
ABPWW 0.0625
ABSI Absci Corporation 2.9
ABUS Arbutus Biopharma Corporation 3.2
ABVC ABVC BioPharma, Inc. 0.54
ABVX Abivax SA American Depositary Shares 6.16
ACAD ACADIA Pharmaceuticals Inc. 17.57
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.92
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.14
ACHV Achieve Life Sciences, Inc. 3.09
ACIU AC Immune SA 2.68
ACLX Arcellx, Inc. 66.48
ACRV Acrivon Therapeutics, Inc. Common Stock 5.74
ETFs With Exposure to MNMD
Ticker ETF Name Weight Percentage Price
SCHB Schwab U.S. Broad Market ETF 0.000849762 23.2
SPDW SPDR Portfolio Developed World ex-US ETF 0.000003 34.655
SCHA Schwab U.S. Small-Cap ETF 0.011705 26.545
GWX SPDR S&P International Small Cap ETF 0.01 30.99
BIB ProShares Ultra Nasdaq Biotechnology 0.0168354 50.46
HDG ProShares Hedge Replication ETF 0.00267986 49.68
UWM ProShares Ultra Russell2000 0.00743462 43.37
XPH SPDR S&P Pharmaceuticals ETF 1.18198 43.79
IWC iShares Micro-Cap ETF 0.04534 129.32
FHLC Fidelity MSCI Health Care Index ETF 0.00501164 66.64
URTY ProShares UltraPro Russell2000 0.00354649 51.69
PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 0.519315 7.41
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 70.65
VTWG Vanguard Russell 2000 Growth Index Fund 0.03 215.307
SPGM SPDR Portfolio MSCI Global Stock Market ETF 0.004103 64.43
IBBQ Invesco Nasdaq Biotechnology ETF 0.049 21.55
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.04927 6.275
EWSA.AS iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.01619 5.23
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.04927 6.27
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000692338 100.37
CUSS.L iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.01417 553.57
SXRG.DE iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.01302 537.5
PSIL AdvisorShares Psychedelics ETF 9.55 12.84
CBUG.DE iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.01478 5.081
CSUSS.MI iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.01379 537.34
RSSL Global X Funds 0.02 88.68
RFLR Innovator ETFs Trust 0.02 25.88
Unlock